Skip to main content
HR 5634 115th Congress House Health Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Health programs administration and funding Licensing and registrations Medical research Veterans' medical care

Medical Cannabis Research Act of 2018

Introduced: April 26, 2018 See on congress.gov
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 13, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 22, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Apr 26, 2018
Referred to the Subcommittee on Health.
Apr 26, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 26, 2018
Introduced in House
 Plain-English summary Congressional Research Service

Medical Cannabis Research Act of 2018

This bill amends the Controlled Substances Act to establish a new, separate registration process for manufacturers of cannabis for research.

The Drug Enforcement Administration must assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.

What's happening now September 13, 2018

Ordered to be Reported (Amended) by Voice Vote.

 Committees of jurisdiction 5